Advertisement
Advertisement
Salofalk

Salofalk Side Effects

mesalazine

Manufacturer:

Dr. Falk

Distributor:

Zuellig

Marketer:

A. Menarini
Full Prescribing Info
Side Effects
Tablet: Gastrointestinal tract side effects: Abdominal pain, diarrhea, flatulence, nausea, vomiting.
Central nervous system side effects: Headache, dizziness, peripheral neuropathy.
Side effects on the kidney
: Impairment of renal function including acute and chronic interstitial nephritis and renal insufficiency.
Hypersensitivity reactions: Allergic skin rash (exanthema), drug fever, spasmodic contraction of the airways (bronchospasm), inflammation of the heart sac and heart muscle (peri- and myocarditis), acute inflammation of the pancreas (pancreatitis), allergic and fibrotic lung reactions (including dyspnoea, cough, alveolitis, pulmonary eosinophilia, lung infiltration, pneumonitis), butterfly rash (lupus erythematosus syndrome), inflammation of the entire large bowel (pancolitis).
Musculoskeletal disorders: Muscle and joint pain (myalgia, arthralgia).
Blood and lymphatic system disorders: Changes in the blood counts (aplastic anaemia, agranulocytosis, pancytopenia, neutropenia, leucopenia, thrombocytopenia).
Disorders of the liver and gall bladder: Changes in liver function tests (raised transaminase and parameters of cholestasis), inflammation of the liver (hepatitis), inflammation of the liver associated with cholestasis (cholestatic hepatitis).
Disorders of the skin and appendages: Hair loss (alopecia) and the development of baldness.
Disorders of the reproductive system: Oligospermia (reversible).
Note: Salofalk 500 mg enteric-coated tablets should be taken under medical supervision.
Granules: See table.

Click on icon to see table/diagram/image

Severe cutaneous adverse reactions (SCARs), including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in association with mesalazine treatment (see Precautions).
Photosensitivity: More severe reactions are reported in patients with pre-existing skin conditions such as atopic dermatitis and atopic eczema.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement